Summary Safety Review - Omnipod Insulin Management System - Assessing the potential risk of malfunctions with the device

March 21, 2018

Product

Omnipod Insulin Management System

Potential Safety Issue

Malfunctions with the device

Key Messages

Overview

In 2014, Health Canada completed a first safety review for the Omnipod because a high number of complaints, reporting high level of blood sugar (hyperglycemia), were received at the time of the review. The review did not find a need for additional safety measures and recommended to actively monitor issues with the Omnipod.

As part of the recommended active monitoring of the Omnipod, Health Canada saw an increase in the number of complaints in the last 3 years about device malfunctions. As a result, Health Canada started another safety review that included an assessment of detailed information provided by the manufacturer and all new complaints reported since the 2014 safety review.

Use in Canada

Safety Review Findings

Conclusions and Actions

Additional Information

The analysis that contributed to this safety review included scientific and medical literature, Canadian and international information and what is known about the use of this medical device both in Canada and internationally.

For additional information, contact the Marketed Health Products Directorate.

Page details

2018-03-19